Teva Pharmaceutical Industries LimitedTEVANYSE
Loading
Cash Flow PerformanceNormalizing
Percentile Rank36
3Y CAGR-12.1%
5Y CAGR+2.8%
Year-over-Year Change
Free cash flow yield
3Y CAGR
-12.1%/yr
vs -1.9%/yr prior
5Y CAGR
+2.8%/yr
Recent deceleration
Acceleration
-10.2pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.05% | +137.7% |
| 2024 | 2.97% | -58.3% |
| 2023 | 7.12% | -31.5% |
| 2022 | 10.39% | +320.8% |
| 2021 | 2.47% | -59.7% |
| 2020 | 6.13% | +57.9% |
| 2019 | 3.88% | -65.4% |
| 2018 | 11.22% | -18.4% |
| 2017 | 13.75% | +10.6% |
| 2016 | 12.43% | - |